Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 6, 2001

View Archived Issues

SomaLogic and Celera Genomics establish aptamer collaboration

Schering AG to amend collaboration agreement with MediGene

FDA approves Medtronic's InSync cardiac resynchronization therapy device

Ivabradine exerts selective bradycardic effects in exercised dogs

Beneficial effects of allopurinol on peripheral blood flow in CHF

Calcium sensitizers may be useful for enhancing myocardial contractile function in septic shock

TNF overproduction attenuated by testosterone in blood from CHF patients

Lysophospholipid receptor ligands designed at U. of Virginia

Antex's product development efforts continue as planned during Q2

Antiviral effect seen for rhIL-12 monotherapy in pilot trial in patients with chronic HCV

Axonyx updates phenserine development progress

Killing kinetics of BMS-284756 compared to other antibiotics

FDA approves Topamax for treatment of Lennox-Gastaut syndrome

CytRx reports positive preclinical results for CRL-5861 in cancer

Multiple DNA cleavage pathways identified for aza-enediyne compound

Phase III results reported for Watson's transdermal oxybutynin patch

Selective TACE inhibitor described as promising drug candidate and pharmacological tool

Vasogen receives clearance to begin pivotal clinical trial of PAD treatment

GSK identifies candidate Y5 antagonist for efficacy studies in obesity

Advanced Viral Research given clearance to move Product R into phase I clinical trials

Urea class yields orally active p38 kinase inhibitors

Selective alpha4beta7 integrin inhibitors and their use described by Japanese lab

Shionogi patents new glycopeptides effective against resistant bacteria

Compounds with tryptase-inhibitory activity designed at Protherics

Preparation, activity and use of new delta opioid receptor ligands reported by Meiji Seika

New series of N-acylpeptide hydrolase inhibitors useful in Rx of CNS diseases

Nikken Chemicals identifies inhibitors of TNF-alpha production

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...